Erlotinib resistance in Lung Cancer: Current Progress and Future Perspectives

Cited by papers we hold 4

• Drug resistance and combating drug resistance in cancer · 2019
  No notice
• Cell death-based treatment of lung adenocarcinoma · 2018
  No notice
• KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer · 2017
  Corrected
• Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.